A phase 1 study of the BCL2-targeted deoxyribonucleic acid inhibitor (DNAi) PNT2258 in patients with advanced solid tumors

Anthony W. Tolcher; Wendi V. Rodrigueza; Drew W. Rasco; Amita Patnaik; Kyriakos P. Papadopoulos; Alex Amaya; Timothy D. Moore; Shari K. Gaylor; Charles L. Bisgaier; Mina P. Sooch; Michael J. Woolliscroft; Richard A. Messmann

journal article

A phase 1 study of the BCL2-targeted deoxyribonucleic acid inhibitor (DNAi) PNT2258 in patients with advanced solid tumors

Authors: Anthony W. Tolcher
Wendi V. Rodrigueza
Drew W. Rasco
Amita Patnaik
Kyriakos P. Papadopoulos
Alex Amaya
Timothy D. Moore
Shari K. Gaylor
Charles L. Bisgaier
Mina P. Sooch
Michael J. Woolliscroft
Richard A. Messmann
Publication date: 2013
Publisher: Springer Nature
Doi

Abstract

Abstract is not available.

journal-article

Similar works

Full text

Open in the Core reader

Download PDF

Springer - Publisher Connector

Last time updated on 03/05/2017

This paper was published in Springer - Publisher Connector.

Having an issue?

Is data on this page outdated, violates copyrights or anything else? Report the problem now and we will take corresponding actions after reviewing your request.